Yuchun Lee, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,190 shares at $276.62 ($2.0M) on 2022-04-08, disclosed to the SEC on 2022-04-12.
Open-market sale of $2.0M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $276.62 | 418 | $116K | 5.8% |
| 2 | $276.62 | 418 | $116K | 5.8% |
| 3 | $277.29 | 430 | $119K | 5.9% |
| 4 | $277.29 | 430 | $119K | 5.9% |
| 5 | $279.36 | 700 | $196K | 9.7% |
| 6 | $280.37 | 452 |
| $127K |
| 6.3% |
| 7 | $280.37 | 452 | $127K | 6.3% |
| 8 | $279.81 | 922 | $258K | 12.8% |
| 9 | $279.81 | 922 | $258K | 12.8% |
| 10 | $280.62 | 968 | $272K | 13.5% |
| 11 | $280.62 | 968 | $272K | 13.5% |
| 12 | $281.58 | 110 | $31K | 1.5% |
| Total | $279.41 avg | 7,190 | $2.0M | 100% |
| Filing → |
| VRTX | SELL | 2023-01-25 | $3.8M | — | Filing → |
| VRTX | SELL | 2023-01-19 | $1.5M | — | Filing → |
| VRTX | SELL | 2022-04-20 | $1.1M | — | Filing → |